With maturity comes confidence: EBCTCG tamoxifen update-Reference-Cited by-同舟云学术

With maturity comes confidence: EBCTCG tamoxifen update

Published:2011-08 Issue:9793 Volume:378 Page:747-749
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chia Stephen K,Wolff Antonio C

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Lancet,2011

2. Global cancer statistics;Jemal;CA Cancer J Clin,2011

3. American Society of Clinical Oncology clinical practice guideline: update of adjuvant endocrine therapy for women with hormone receptor-positive breast cancer;Burstein;J Clin Oncol,2010

4. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol,2010

5. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen;Dowsett;J Clin Oncol,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature;Breast Cancer Research and Treatment;2022-05-19

2. The predictive potential of Neuronatin for neoadjuvant chemotherapy of breast cancer;Cancer Biomarkers;2021-09-24

3. Clinical Applications of Extracellular Vesicles in the Diagnosis and Treatment of Traumatic Brain Injury;Journal of Neurotrauma;2020-10-01

4. Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies;ESMO Open;2020

5. Time resolved gene expression analysis during tamoxifen adaption of MCF-7 cells identifies long non-coding RNAs with prognostic impact;RNA Biology;2019-03-05